Insights on the Pharmaceutical Glass Packaging Global Market to 2027 - by Product, Drug Type, Application and Region

2022-07-29 19:55:01 By : Mr. Andrew Wei

888-776-0942 from 8 AM - 10 PM ET

DUBLIN , June 8, 2022 /PRNewswire/ -- The "Pharmaceutical Glass Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical glass packaging market reached a value of US$ 8.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 12.63 Billion by 2027 exhibiting a CAGR of 7.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Glass is widely utilized as a packaging material for various pharmaceutical products. Some commonly used pharmaceutical glass packaging solutions include ultra-resistant borosilicate glass, surface treated soda-lime glass, regular soda-lime glass, and general-purpose soda-lime glass. It restricts atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, thus eliminating the risk of contamination of the medicines.

It also helps extend the shelf life of pharmaceutical products and prevents the escape of volatile ingredients, thereby increasing drug stability. Moreover, colored glass, such as amber and red-colored glass, can protect the contents from ultraviolet (UV) rays and specific wavelengths. In recent years, pharmaceutical glass packaging has rapidly gained traction due to its excellent strength, durability, transparency, recyclability, and chemical resistance. Pharmaceutical glass packaging protects the contents against physical damage, prevents biological contamination, and reduces the drug's susceptibility to degradation, such as hydrolysis and oxidation. As a result, the expanding pharmaceutical industry represents the primary factor driving the market growth.

Additionally, the growing need to extend the shelf life of medicinal products and the rising consumption of generic drugs and injectables are augmenting the product demand. Besides this, the widespread prevalence of chronic diseases like diabetes, increasing healthcare awareness among the masses, and elevating income levels are catalyzing the market growth.

Furthermore, governments of various countries are taking several favorable initiatives to encourage the usage of recycled glass to reduce the carbon footprint and ensure a safer and greener environment. Along with this, the launch of thin and lightweight glass bottles by leading manufacturers to minimize the overall consumption of energy and raw materials is propelling the market growth.

Other factors, including the emerging applications of glass bottles, improving healthcare infrastructure, rising environmental concerns, ongoing research and development (R&D) activities, and technological advancements, are also providing a positive thrust to the market growth.

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Piramal Enterprises Ltd., Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Sisecam (Turkiye Is Bankasi A.S.), Stolzle-Oberglas GmBH and West Pharmaceutical Services Inc. Key Questions Answered in This Report:

Key Topics Covered: 1 Preface 2 Scope and Methodology

3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Pharmaceutical Glass Packaging Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Bottles 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Vials 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Ampoules 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Cartridges and Syringes 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Drug Type 7.1 Generic 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Branded 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Biologic 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Injectable 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Nasal 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Ardagh Group S.A 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Beatson Clark 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Bormioli Pharma S.p.A. 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Corning Incorporated 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Gerresheimer AG 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.6 Nipro Corporation 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Piramal Enterprises Ltd. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.8 Schott AG 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 SWOT Analysis 14.3.9 SGD Pharma 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Shandong Pharmaceutical Glass Co. Ltd. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.11 ?i?ecam (Turkiye ?? Bankas? A.?.) 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.12 Stolzle-Oberglas GmBH 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.13 West Pharmaceutical Services Inc. 14.3.13.1 Company Overview 14.3.13.2 Product Portfolio 14.3.13.3 Financials 14.3.13.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/648uuv

Research and Markets Laura Wood , Senior Manager [email protected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

More news releases in similar topics

Cision Distribution 888-776-0942 from 8 AM - 9 PM ET